Conversely, higher peanut-specific IgG4 or a higher peanut-specific IgA:IgE or IgG4:IgE ratio in saliva correlated with lower odds of severe reactions and lower likelihood of peanut allergy, underscoring the potential utility of saliva antibody profiling in clinical evaluation. Here, CD79A is linked to peanut allergic reaction.